Ocean Biomedical, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 67.4 million compared to USD 5.38 million a year ago. Basic loss per share from continuing operations was USD 2.72 compared to USD 0.23 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | +2.80% | -.--% | +122.73% |
30/05 | Ocean Biomedical Gets Nasdaq Noncompliance Notice; Shares Down | MT |
15/04 | Ocean Biomedical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+122.73% | 49.55M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- OCEA Stock
- News Ocean Biomedical, Inc.
- Ocean Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023